The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry
Annelie H. Musters, Conor Broderick, David Prieto-Merino, Andrea Chiricozzi, Giovanni Damiani, Ketty Peris, Sandipan Dhar, Abhishek De, Esther Freeman, Bernd W.M. Arents, Tim Burton, Angela Leigh Ann L. Bosma, Ching Chi Chi, Godfrey Fletcher, Aaron M. Drucker, Kenji Kabashima, Emilie F. de Monchy, Maitreyee Panda, Dmitri Robert Wall, Christian Vestergaard
*此作品的通信作者
- University of Amsterdam
- Guy's and St Thomas' NHS Foundation Trust
- London School of Hygiene and Tropical Medicine
- Fondazione Policlinico Universitario “Agostino Gemelli” IRCCS
- Catholic University of the Sacred Heart
- IRCCS Istituto Ortopedico Galeazzi - Milano
- University of Milan
- University of Padua
- Institute of Child Health Kolkata
- West Bengal University of Health Sciences
- Harvard University
- Dutch Association for People with Atopic Dermatitis
- Patient Representative (independent)
- University College Dublin
- University of Toronto
- Kyoto University
- Agency for Science, Technology and Research, Singapore
- Siksha ‘O’ Anusandhan University
- Hair Restoration Blackrock
- Aarhus University
- Centre Hospitalier Victor Dupouy d'Argenteuil
- IRCCS Azienda Unità Sanitaria Locale di Reggio Emilia
- University of Molise
- Hospital Militar Central
- Technische Universität Dresden
- Magna Græcia University
- Trinity College Dublin
研究成果: 期刊稿件 › 文章 › 同行評審
8
引文
斯高帕斯(Scopus)